U.S. administers over 420 million doses of COVID-19 vaccines

© Reuters. FILE PHOTO: A nurse prepares a Pfizer BioNTech coronavirus disease (COVID-19) vaccination as part of a vaccine drive by the Fernandeno Tataviam Band of Mission Indians in Arleta, Los Angeles, California, U.S., August 23, 2021. REUTERS/Lucy Nicholson

(Reuters) – The United States has administered 420,657,683 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 518,701,225 doses, the U.S. Centers for Disease Control and Prevention said.

Those figures are up from the 419,020,753 vaccine doses the CDC said had gone into arms by Oct. 29 out of 514,925,015 doses delivered.

The agency said 221,221,467 people had received at least one dose while 192,244,927 people were fully vaccinated as of 6:00 a.m. ET on Saturday.

The CDC tally includes two-dose vaccines from Moderna (NASDAQ:) and Pfizer/BioNTech, as well as Johnson & Johnson (NYSE:)’s one-shot vaccine.

About 17.7 million people have received a booster dose of either Pfizer (NYSE:), Moderna or Johnson & Johnson’s COVID-19 vaccine. Booster doses from Moderna and Johnson & Johnson were authorized by the U.S. health regulator on Oct. 20.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Be the first to comment

Leave a Reply

Your email address will not be published.


*